CASI Pharmaceuticals Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
15 Jul 24 | BuyUS$1,500,000 | Wei-Wu He | Individual | 300,000 | US$5.00 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Institutions | 386,867 | 2.57% |
Individual Insiders | 775,224 | 5.15% |
Private Companies | 908,788 | 6.04% |
General Public | 6,386,483 | 42.4% |
VC/PE Firms | 6,591,143 | 43.8% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 13%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
1,873,731 | US$9.9m | 0% | 0.66% | |||
1,323,429 | US$7.0m | 30% | 12.75% | |||
1,309,383 | US$6.9m | 0% | 2.21% | |||
1,097,341 | US$5.8m | 0% | 100.0% | |||
987,259 | US$5.2m | 784% | 0.24% | |||
908,788 | US$4.8m | 0% | no data | |||
763,209 | US$4.0m | 11.1% | no data | |||
132,308 | US$695.9k | 0% | 0.08% | |||
64,835 | US$341.0k | 687% | 0.06% | |||
50,000 | US$263.0k | 0% | no data | |||
41,500 | US$218.3k | 1.72% | no data | |||
30,532 | US$160.6k | 0% | no data | |||
22,714 | US$119.5k | 0% | no data | |||
19,363 | US$101.8k | -12.9% | no data | |||
14,681 | US$77.2k | 29.7% | no data | |||
10,000 | US$52.6k | 0% | no data | |||
6,900 | US$36.3k | 0% | no data | |||
2,015 | US$10.6k | 0% | no data | |||
1,927 | US$10.1k | 0% | no data | |||
1,440 | US$7.6k | 0% | no data | |||
506 | US$2.7k | 0% | no data | |||
296 | US$1.6k | 0% | no data | |||
100 | US$522.4 | 0% | no data | |||
28 | US$150.4 | -47.2% | no data | |||
25 | US$134.6 | 0% | no data |